Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction

PROTEIN & CELL

OXFORD UNIV PRESS

1. NIH [R01AR062207, R01AR061484, R01NS103931, R01AR076900]